These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 9312107

  • 1. Co-expression of defective luteinizing hormone receptor fragments partially reconstitutes ligand-induced signal generation.
    Osuga Y, Hayashi M, Kudo M, Conti M, Kobilka B, Hsueh AJ.
    J Biol Chem; 1997 Oct 03; 272(40):25006-12. PubMed ID: 9312107
    [Abstract] [Full Text] [Related]

  • 2. The C-terminal third of the human luteinizing hormone (LH) receptor is important for inositol phosphate release: analysis using chimeric human LH/follicle-stimulating hormone receptors.
    Hirsch B, Kudo M, Naro F, Conti M, Hsueh AJ.
    Mol Endocrinol; 1996 Sep 03; 10(9):1127-37. PubMed ID: 8885247
    [Abstract] [Full Text] [Related]

  • 3. Characterization of a region of the lutropin receptor extracellular domain near transmembrane helix 1 that is important in ligand-mediated signaling.
    Alvarez CA, Narayan P, Huang J, Puett D.
    Endocrinology; 1999 Apr 03; 140(4):1775-82. PubMed ID: 10098515
    [Abstract] [Full Text] [Related]

  • 4. Derivation of functional antagonists using N-terminal extracellular domain of gonadotropin and thyrotropin receptors.
    Osuga Y, Kudo M, Kaipia A, Kobilka B, Hsueh AJ.
    Mol Endocrinol; 1997 Oct 03; 11(11):1659-68. PubMed ID: 9328348
    [Abstract] [Full Text] [Related]

  • 5. Identification of amino acid residues in transmembrane helices VI and VII of the lutropin/choriogonadotropin receptor involved in signaling.
    Fernandez LM, Puett D.
    Biochemistry; 1996 Apr 02; 35(13):3986-93. PubMed ID: 8672431
    [Abstract] [Full Text] [Related]

  • 6. Transmembrane regions V and VI of the human luteinizing hormone receptor are required for constitutive activation by a mutation in the third intracellular loop.
    Kudo M, Osuga Y, Kobilka BK, Hsueh AJ.
    J Biol Chem; 1996 Sep 13; 271(37):22470-8. PubMed ID: 8798412
    [Abstract] [Full Text] [Related]

  • 7. Expression of human luteinizing hormone (LH) receptor: interaction with LH and chorionic gonadotropin from human but not equine, rat, and ovine species.
    Jia XC, Oikawa M, Bo M, Tanaka T, Ny T, Boime I, Hsueh AJ.
    Mol Endocrinol; 1991 Jun 13; 5(6):759-68. PubMed ID: 1922095
    [Abstract] [Full Text] [Related]

  • 8. Phe576 plays an important role in the secondary structure and intracellular signaling of the human luteinizing hormone/chorionic gonadotropin receptor.
    Yano K, Kohn LD, Saji M, Okuno A, Cutler GB.
    J Clin Endocrinol Metab; 1997 Aug 13; 82(8):2586-91. PubMed ID: 9253338
    [Abstract] [Full Text] [Related]

  • 9. Co-evolution of ligand-receptor pairs.
    Moyle WR, Campbell RK, Myers RV, Bernard MP, Han Y, Wang X.
    Nature; 1994 Mar 17; 368(6468):251-5. PubMed ID: 8145825
    [Abstract] [Full Text] [Related]

  • 10. Expression of extracellular domain peptides of the FSH receptor and their effect on receptor-ligand interactions in vitro.
    Sharma SC, Catterall JF.
    Mol Cell Endocrinol; 1995 Nov 30; 115(1):87-93. PubMed ID: 8674868
    [Abstract] [Full Text] [Related]

  • 11. The nematode leucine-rich repeat-containing, G protein-coupled receptor (LGR) protein homologous to vertebrate gonadotropin and thyrotropin receptors is constitutively active in mammalian cells.
    Kudo M, Chen T, Nakabayashi K, Hsu SY, Hsueh AJ.
    Mol Endocrinol; 2000 Feb 30; 14(2):272-84. PubMed ID: 10674399
    [Abstract] [Full Text] [Related]

  • 12. Activation of the luteinizing hormone receptor following substitution of Ser-277 with selective hydrophobic residues in the ectodomain hinge region.
    Nakabayashi K, Kudo M, Kobilka B, Hsueh AJ.
    J Biol Chem; 2000 Sep 29; 275(39):30264-71. PubMed ID: 10889210
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Lutropins appear to contact two independent sites in the extracellular domain of their receptors.
    Bernard MP, Myers RV, Moyle WR.
    Biochem J; 1998 Nov 01; 335 ( Pt 3)(Pt 3):611-7. PubMed ID: 9794802
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The regulation of the binding affinity of the luteinizing hormone/choriogonadotropin receptor by sodium ions is mediated by a highly conserved aspartate located in the second transmembrane domain of G protein-coupled receptors.
    Quintana J, Wang H, Ascoli M.
    Mol Endocrinol; 1993 Jun 01; 7(6):767-75. PubMed ID: 8395653
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ligand-induced down-regulation of testicular and ovarian luteinizing hormone (LH) receptors is preceded by tissue-specific inhibition of alternatively processed LH receptor transcripts.
    LaPolt PS, Jia XC, Sincich C, Hsueh AJ.
    Mol Endocrinol; 1991 Mar 01; 5(3):397-403. PubMed ID: 1890990
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.